Corium International Inc (CORI):企業の製品パイプライン分析2018

GlobalDataが発行した調査報告書(DATA904C2889)
◆英語タイトル:Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2889
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer’s disease. Corium also develops MicroCor PTH for the treatment of osteoporosis using another technology platform called MicroCor system. The company provides proprietary development programs, contract research and development services. It partners with pharmaceutical and consumer products companies. The company operates through its research and development facility in Grand Rapids, the US. Corium is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Corium International Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Corium International Inc Company Overview 5
Corium International Inc Company Snapshot 5
Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Corium International Inc – Pipeline Analysis Overview 7
Corium International Inc – Key Facts 7
Corium International Inc – Major Products and Services 8
Corium International Inc Pipeline Products by Development Stage 9
Corium International Inc Ongoing Clinical Trials by Trial Status 11
Corium International Inc Pipeline Products Overview 12
Corplex Donepezil Transdermal System 12
Corplex Donepezil Transdermal System Product Overview 12
Corplex Donepezil Transdermal System Clinical Trial 13
Corplex Memantine Transdermal System 14
Corplex Memantine Transdermal System Product Overview 14
Corplex Ropinirole Transdermal System 15
Corplex Ropinirole Transdermal System Product Overview 15
Island Dressing 16
Island Dressing Product Overview 16
MicroCor Transdermal System 17
MicroCor Transdermal System Product Overview 17
MicroCor Zolmitriptan System 18
MicroCor Zolmitriptan System Product Overview 18
MicroJet 19
MicroJet Product Overview 19
Rapidly Dissolving Film 20
Rapidly Dissolving Film Product Overview 20
Solid State Film 21
Solid State Film Product Overview 21
Corium International Inc – Key Competitors 22
Corium International Inc – Key Employees 23
Corium International Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corium International Inc, Recent Developments 25
Jul 11, 2018: Corium Announces Issuance of Additional U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer”s Disease 25
Jun 13, 2018: Corium Announces Issuance of Key U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer’s Disease 25
May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results 26
Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights 27
Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights 28
Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 29
Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer’s Association International Conference 2017 30
Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer’s Association International Conference 2017 30
May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights 31
May 11, 2017: Corium Reports Positive Preliminary Results in Alzheimer’s Clinical Study 32
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Corium International Inc Pipeline Products by Equipment Type 6
Corium International Inc Pipeline Products by Indication 6
Corium International Inc Ongoing Clinical Trials by Trial Status 6
Corium International Inc, Key Facts 7
Corium International Inc, Major Products and Services 8
Corium International Inc Number of Pipeline Products by Development Stage 9
Corium International Inc Pipeline Products Summary by Development Stage 10
Corium International Inc Ongoing Clinical Trials by Trial Status 11
Corium International Inc Ongoing Clinical Trials Summary 11
Corplex Donepezil Transdermal System - Product Status 12
Corplex Donepezil Transdermal System - Product Description 12
Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease 13
Corplex Memantine Transdermal System - Product Status 14
Corplex Memantine Transdermal System - Product Description 14
Corplex Ropinirole Transdermal System - Product Status 15
Corplex Ropinirole Transdermal System - Product Description 15
Island Dressing - Product Status 16
Island Dressing - Product Description 16
MicroCor Transdermal System - Product Status 17
MicroCor Transdermal System - Product Description 17
MicroCor Zolmitriptan System - Product Status 18
MicroCor Zolmitriptan System - Product Description 18
MicroJet - Product Status 19
MicroJet - Product Description 19
Rapidly Dissolving Film - Product Status 20
Rapidly Dissolving Film - Product Description 20
Solid State Film - Product Status 21
Solid State Film - Product Description 21
Corium International Inc, Key Employees 23
Corium International Inc, Other Locations 24
Glossary 36

List of Figures
Corium International Inc Pipeline Products by Equipment Type 6
Corium International Inc Pipeline Products by Development Stage 9
Corium International Inc Ongoing Clinical Trials by Trial Status 11

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Corium International Inc (CORI):企業の製品パイプライン分析2018(Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆